OPK
Closed
Opko Health Inc
1.325
+0.005 (+0.38%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.32
Day's Range: 1.31 - 1.36
Send
sign up or login to leave a comment!
When Written:
1.46
Opko Health Inc. is a multinational healthcare company that focuses on diagnostics and pharmaceuticals. The company was founded in 1991 and is headquartered in Miami, Florida. Opko Health has operations in the United States, Chile, Ireland, and Spain.
Opko Health's diagnostics business includes the development, manufacture, and distribution of point-of-care tests, laboratory tests, and molecular diagnostics. The company's pharmaceuticals business includes the development and commercialization of drugs for the treatment of various diseases, including cancer, diabetes, and cardiovascular disease.
Opko Health has several subsidiaries, including Bio-Reference Laboratories, which provides laboratory testing services, and GeneDx, which provides genetic testing services. The company also has a joint venture with Pfizer called Biohaven Pharmaceuticals, which is focused on developing treatments for neurological disorders.
Opko Health is publicly traded on the NASDAQ stock exchange under the ticker symbol OPK. As of 2021, the company has a market capitalization of approximately $3.6 billion.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Opko Health's diagnostics business includes the development, manufacture, and distribution of point-of-care tests, laboratory tests, and molecular diagnostics. The company's pharmaceuticals business includes the development and commercialization of drugs for the treatment of various diseases, including cancer, diabetes, and cardiovascular disease.
Opko Health has several subsidiaries, including Bio-Reference Laboratories, which provides laboratory testing services, and GeneDx, which provides genetic testing services. The company also has a joint venture with Pfizer called Biohaven Pharmaceuticals, which is focused on developing treatments for neurological disorders.
Opko Health is publicly traded on the NASDAQ stock exchange under the ticker symbol OPK. As of 2021, the company has a market capitalization of approximately $3.6 billion.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!